Therefore, released HMGB1 could activate the MyD88 pathway in tumor cells and mediate amplification of angiogenesis which can be complementary to the direct effect of HMGB1 on endothelial cells to enhance the expression of proteins involved in proangiogenic cascades, thus contributing to tumor vascularization [42]. The gene discussed is MYD88; the disease is neoplasm.